IECURE
Company Overview
Social Media Profiles
About iECURE
Description
iECURE focuses on in vivo gene editing to address critical patient needs in the biotechnology and life sciences sector. Committed to transforming patient outcomes, the company aims to reverse the progression of devastating conditions through innovative gene therapies, fostering hope for affected individuals.
Specialties
In vivo gene editing
Gene therapy for liver diseases
Mutation-agnostic therapies
Long-term gene expression
Collaboration with University of Pennsylvania
Products & Services
In vivo gene editing therapies
Gene therapy for liver diseases
Clinical trials for genetic disorders
Mutation-agnostic treatment methods
Stable gene expression solutions
Contact Information
No contact information available
Competitors & Similar Companies(9)
CRISPR Therapeutics
Massachusetts, • United States
Editas Medicine
Massachusetts, • United States
Intellia Therapeutics
Massachusetts, • United States
Regenxbio
Maryland, • United States
Sangamo Therapeutics
British Columbia, • Canada
Beam Therapeutics
Massachusetts, • United States
Bluebird Bio
Massachusetts, • United States
Unitaid
Caribou Biosciences
California, • United States
News & Media
Search Terms:
iecure
Search Topics:
AcquisitionAI: Product LaunchInvestment: Approval FundingProject: Bid and AuctionBusiness ExpansionFinancing and FundraisingInvestmentJoint VentureLeadership Change (CXO)MergerPartnershipProduct LaunchPublic Offering (IPO)RebrandingReorganizationRestructuringValuation
Loading...
Frequently Asked Questions about iECURE
Where is iECURE located?
The headquarter of iECURE is located in Plymouth Meeting, Pennsylvania, United States
What is the official website of iECURE?
The official website of iECURE is https://www.iecure.com
What industry does iECURE belong to?
iECURE belongs to the Biotechnology, Biotechnology and Life Sciences industry.
What are the specialties of iECURE?
iECURE specializes in In vivo gene editing, Gene therapy for liver diseases, Mutation-agnostic therapies, Long-term gene expression, Collaboration with University of Pennsylvania.
What products and services is iECURE likely to offer?
iECURE offers In vivo gene editing therapies, Gene therapy for liver diseases, Clinical trials for genetic disorders, Mutation-agnostic treatment methods, Stable gene expression solutions.
Who are the competitors of iECURE?
Competitors of iECURE are CRISPR Therapeutics, Editas Medicine, Intellia Therapeutics, Regenxbio, Sangamo Therapeutics, Beam Therapeutics, Bluebird Bio, Unitaid, Caribou Biosciences.
What does iECURE do?
iECURE focuses on in vivo gene editing to address critical patient needs in the biotechnology and life sciences sector. Committed to transforming patient outcomes, the company aims to reverse the progression of devastating conditions through innovative gene therapies, fostering hope for affected individuals.
What are the social media links of iECURE?
Social media links of iECURE areLinkedIn